http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100915670-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-39 |
| filingDate | 2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100915670-B1 |
| titleOfInvention | A novel YlMPO1 gene derived from Yarrowia lipolytica and a process for preparing a glycoprotein not being mannosylphosphorylated by using a mutated Yarrowia lipolytica in which YlMPO1 gene is disrupted |
| abstract | The present invention provides a novel gene YlMPO1 that plays an important role in the process of mannosylphosphorylation of industrial yeast Yarrowia lipolytica , and a method of making a recombinant glycoprotein production host that does not add mannose phosphoric acid by crushing the gene. It is about. The YlMPO1 gene disruption of the present invention prevents the addition of mannose phosphoric acid, which is absent in humans, and thus can be efficiently used to humanize the oligosaccharide biosynthetic pathway of Yarrowia lipolitica yeast. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016048046-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012067466-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012067466-A2 |
| priorityDate | 2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 927.